These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. Luxton G; Hancock SL; Boyer AL Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924 [TBL] [Abstract][Full Text] [Related]
4. Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: rationale, technique and early experience. Koukourakis MI; Touloupidis S; Manavis J; Abatzoglou I; Sismanidou K; Sivridis L Anticancer Res; 2004; 24(5B):3239-43. PubMed ID: 15510617 [TBL] [Abstract][Full Text] [Related]
5. Radiotherapy of prostate cancer with multileaf collimators (MLCs) optimization of the undulating dose distribution at the MLC edge. Koelbl O; Schwab F; Bratengeier K; Vordermark D; Flentje M Strahlenther Onkol; 2005 Feb; 181(2):108-12. PubMed ID: 15702299 [TBL] [Abstract][Full Text] [Related]
6. IMRT: improvement in treatment planning efficiency using NTCP calculation independent of the dose-volume-histogram. Grigorov GN; Chow JC; Grigorov L; Jiang R; Barnett RB Med Phys; 2006 May; 33(5):1250-8. PubMed ID: 16752559 [TBL] [Abstract][Full Text] [Related]
7. Statistical analysis of dose-volume and dose-wall histograms for rectal toxicity following 3D-CRT in prostate cancer. García-Vicente F; Zapatero A; Floriano A; Cruz-Conde A; Perez L; Marín A; Mínguez C; Torres JJ Med Phys; 2005 Aug; 32(8):2503-9. PubMed ID: 16193780 [TBL] [Abstract][Full Text] [Related]
8. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy. Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815 [TBL] [Abstract][Full Text] [Related]
9. Response-probability volume histograms and iso-probability of response charts in treatment plan evaluation. Mavroidis P; Ferreira BC; Lopes Mdo C Med Phys; 2011 May; 38(5):2382-97. PubMed ID: 21776773 [TBL] [Abstract][Full Text] [Related]
10. Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study. Tramacere F; Arcangeli S; Pignatelli A; Castagna R; Portaluri M Anticancer Res; 2015 May; 35(5):3049-54. PubMed ID: 25964594 [TBL] [Abstract][Full Text] [Related]
11. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP). Jensen I; Carl J; Lund B; Larsen EH; Nielsen J Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692 [TBL] [Abstract][Full Text] [Related]
12. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer. Chera BS; Vargas C; Morris CG; Louis D; Flampouri S; Yeung D; Duvvuri S; Li Z; Mendenhall NP Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):994-1002. PubMed ID: 19619961 [TBL] [Abstract][Full Text] [Related]
13. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer. Luo C; Yang CC; Narayan S; Stern RL; Perks J; Goldberg Z; Ryu J; Purdy JA; Vijayakumar S Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1253-62. PubMed ID: 17145540 [TBL] [Abstract][Full Text] [Related]
14. Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: a volumetric dose measurement study. Duan J; Shen S; Fiveash JB; Popple RA; Brezovich IA Med Phys; 2006 May; 33(5):1380-7. PubMed ID: 16752574 [TBL] [Abstract][Full Text] [Related]
15. On-line re-optimization of prostate IMRT plans for adaptive radiation therapy. Wu QJ; Thongphiew D; Wang Z; Mathayomchan B; Chankong V; Yoo S; Lee WR; Yin FF Phys Med Biol; 2008 Feb; 53(3):673-91. PubMed ID: 18199909 [TBL] [Abstract][Full Text] [Related]
16. Improving delivery of segments with small MU in step-and-shoot IMRT. Kuperman VY; Lam WC Med Phys; 2006 Apr; 33(4):1067-73. PubMed ID: 16696483 [TBL] [Abstract][Full Text] [Related]
17. A cylindrical model of the rectum: comparing dose-volume, dose-surface and dose-wall histograms in the radiotherapy of prostate cancer. Fiorino C; Gianolini S; Nahum AE Phys Med Biol; 2003 Aug; 48(16):2603-16. PubMed ID: 12974577 [TBL] [Abstract][Full Text] [Related]
18. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy. Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638 [TBL] [Abstract][Full Text] [Related]
19. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition. Ganswindt U; Paulsen F; Corvin S; Eichhorn K; Glocker S; Hundt I; Birkner M; Alber M; Anastasiadis A; Stenzl A; Bares R; Budach W; Bamberg M; Belka C BMC Cancer; 2005 Jul; 5():91. PubMed ID: 16048656 [TBL] [Abstract][Full Text] [Related]
20. Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol. Mott JH; Livsey JE; Logue JP Br J Radiol; 2004 May; 77(917):377-86. PubMed ID: 15121701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]